Goldman Sachs’s MaxLinear MXL Stock Holding History

Goldman Sachs’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.78M	Buy	+29,500	New	+$2.09M	﹤0.01%	4141

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs's MXL Position: Q2 2026 in Review

Goldman Sachs reduced its MaxLinear (MXL) stake by 36% in Q2 2026, selling an estimated $37.2M and leaving 919,249 shares worth $118M. The position accounts for 0.01% of the portfolio, ranked #1112.

Goldman Sachs first reported a position in MXL in Q1 2014 and has held it in 49 quarters since. 432 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

Goldman Sachs held 919,249 shares of MaxLinear worth $118M as of Q2 2026.
Goldman Sachs sold 525,824 MaxLinear shares in Q2 2026, an estimated $37.2M.
MaxLinear made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1112 holding.
Goldman Sachs first reported a position in MaxLinear in Q1 2014 and has held it in 49 quarters since.
432 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.